Mice were treated intraperitoneally with 1 mg of anti-IFN-αR-1 clone MAR1–5A3 (Leinco, MO, USA), isotype immunoglobulin 1 (Leinco), 500 or 50 μg of anti-TNF-α clone XT3.11 (Bio X Cell, NH, USA) (42 (link)), or 250 μg of anti-IFN-γ clone XMG1.2 (Bio X Cell) (43 (link)). Mice were injected with 200 μg of poly I:C (Tocris, Bristol, UK).